If you examine the poster from the conference presentation you'll see tick marks in the Kaplan-Meier plot. Each tick mark represents a censored event which means the patient left the trial. For stats purposes a pt that leaves is considered to have survived. Notice that each vertical step gets larger and larger as more and more patients get censored. I suspect (just my opinion) that the trial in now underpowered and the primary endpoint won't meet statistical significance. The p value must be below 0.05 for statistical significance.
Cheers.
Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials, page-339
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
0.001(2.04%) |
Mkt cap ! $371.8M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $262.8K | 5.378M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 700408 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 5672796 | 18 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |